New technique to repurpose fibroblasts into functional melanocytes.
Read more
"Therapeutic C3 inhibitor Cp40 abrogates complement activation induced by modern hemodialysis filters" published in Immunobiology.
Read more
Highlights of the new trial results include a response rate of more than 90 percent among pediatric ALL patients, and results from the first lymphoma trials testing the approach, including a 100 percent response rate among follicular lymphoma patients and 45 percent response rate among those with diffuse large B cell lymphoma.
Read more
Dr. Kamoun assumes the 2014-15 Presidency of the American Society for Histocompatibility and Immunogenetics (ASHI).
Read more
Wallace Lab findings challenge the traditional “single mutation–single disease” concept and provide an alternative perspective into understanding the underlying cause of metabolic and neurodegenerative disorders.
Read more
Michael P. Cancro, PhD, is one of three recipients of grants totaling $3.4 million that have been awarded by the U.S. Department of Defense (DOD) for lupus research.
Read more
The Defense Advanced Research Projects Agency (DARPA) has awarded $12.2 million for a project to develop DNA-based monoclonal antibodies (mAbs) for infectious disease treatment.
Read more
Ninety percent of children and adults with acute lymphoblastic leukemia (ALL) who had relapsed multiple times or failed to respond to standard therapies went into remission after receiving an investigational personalized cellular therapy, CTL019, developed at the Perelman School of Medicine at the University of Pennsylvania. The unprecedented results are published this week in The New England Journal of Medicine.
Read more
Honors for Dr. Virginia LiVolsi, Dr. Zubair Baloch, and fourth-year resident Dr. Sam Wei.
Read more
The Department mourns the death of Dr. Nicholas Gonatas, Professor of Pathology and Laboratory Medicine, luminary neuropathologist, world-class researcher, founder of the Division of Neuropathology at Penn, and outstanding teacher and mentor to scores of pathology fellows, residents, graduate students, and postdoctoral fellows.
Read more
Pages
